Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine in Recurrent Small Cell Lung Cancer
NCT00168922Phase 2Unknown
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Feb 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in small cell lung cancer (SCLC), sponsored by Charité – Universitätsmedizin Berlin. Status: unknown.
02
Drugs
bendamustine
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00168922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00168922.